Post Pancreatitis Complications Study (Based on a Prospective Data Base)

June 2, 2020 updated by: Nantes University Hospital

Prospective Cohort of Patients With Pancreatitis Hospitalized in West French Intensive Care Units

The purpose of this observational epidemiological study is to investigate the management and the complications associated with pancreatitis. Datas will be analysed to answer pre-defined scientific projects and to improve management of these conditions.

Study Overview

Status

Withdrawn

Conditions

Intervention / Treatment

Detailed Description

Anonymous datas will be collected by study coordinators in a secured e-database.

Cross audit will be performed to check datas.

Study Type

Observational

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Angers, France, 49000
        • Angers University Hospital
      • Nantes, France, 44093
        • Nantes University Hospital
      • Poitiers, France, 86000
        • Poitiers university hospital
      • Rennes, France, 35000
        • Rennes University Hospital
      • Tours, France, 37000
        • Tours university Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients with pancreatitis hospitalized in ICU

Description

Inclusion Criteria:

  • pancreatitis

Exclusion Criteria:

  • consent withdrawal

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
ICU patients
Patients with pancreatitis
Other: Collection of medical datas from ICU patients
Collection of medical datas from ICU patients with pancreatitis on a secured electronic database

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
In ICU stay main complications
Time Frame: Within the 28 first days after ICU admission date
Nosocomial Infections (epidemiology, risk factors, antibiotic susceptibility of pathogens) Organ failures (incidence, risk factors)
Within the 28 first days after ICU admission date

Secondary Outcome Measures

Outcome Measure
Time Frame
Duration of Mechanical Ventilation
Time Frame: During ICU stay (up to 90 days)
During ICU stay (up to 90 days)
Length of ICU stay
Time Frame: During ICU stay (up to 90 days)
During ICU stay (up to 90 days)

Other Outcome Measures

Outcome Measure
Time Frame
Death
Time Frame: During ICU stay (up to 90 days)
During ICU stay (up to 90 days)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Nantes University Hospital

Investigators

  • Study Chair: Karim Asehnoune, MD,PhD, Non-Affiliated

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

April 1, 2013

Primary Completion (Actual)

June 1, 2020

Study Completion (Actual)

June 1, 2020

Study Registration Dates

First Submitted

September 14, 2017

First Submitted That Met QC Criteria

September 14, 2017

First Posted (Actual)

September 15, 2017

Study Record Updates

Last Update Posted (Actual)

June 4, 2020

Last Update Submitted That Met QC Criteria

June 2, 2020

Last Verified

June 1, 2020

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • RC12_0207 doublon 2

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pancreatitis

Clinical Trials on Collection of medical datas from ICU patients

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Canada

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe